I call the meeting back to order.
I'd like to welcome our witnesses for the second panel.
I have just a few comments for the benefit of the new witnesses, specifically Dr. Ahmed, who is participating online.
Dr. Ahmed, you have interpretation on your screen. You have the choice of either floor, English or French.
For those in the room, you can use the earpiece to select the desired channel.
Mr. Garon, I can confirm that sound and connection tests have been carried out with Dr. Ahmed and that the sound quality is good.
I would now like to welcome our next panel of witnesses.
From the Association québécoise des distributeurs en pharmacie, we have Mr. Hugues Mousseau, director general.
From Children's Healthcare Canada, we have Emily Gruenwoldt, president and chief executive officer.
From the Critical Drugs Coalition, we have Dr. Saad Ahmed, physician, appearing by video conference from Vancouver.
Finally, from Food, Health & Consumer Products of Canada, we have Gerry Harrington, senior adviser.
Thanks to all.
Mr. Mousseau, I invite you to begin. You have five minutes for your opening statement. Welcome to the committee, sir.
You have the floor.